Orazio Caffo

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.

Giampietro Gasparini, Noel Weidner, Pierantonio Bevilacqua et al. · Journal of Clinical Oncology · 1994 · 466 citations

Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial—FIRSTANA

Stéphane Oudard, Karim Fizazi, Lisa Sengeløv et al. · Journal of Clinical Oncology · 2017 · 350 citations

High syndecan‐1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis

Mattia Barbareschi, Patrick Maisonneuve, D Aldovini et al. · Cancer · 2003 · 237 citations

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone

Cristian Lolli, Orazio Caffo, Emanuela Scarpi et al. · Frontiers in Pharmacology · 2016 · 198 citations · Full text

Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.

Giampietro Gasparini, Mattia Barbareschi, Claudio Doglioni et al. · PubMed · 1995 · 196 citations

Breast Oncology, Endocrine-related Cancer, Bcl-2 Protein Expression +15